Skip to main content
Top
Published in: Inflammation Research 10/2020

01-10-2020 | Famotidine | Meeting Report

Meeting report of the 49th annual meeting of the European Histamine Research Society (EHRS)

Authors: Linda Kay, Ilona Obara

Published in: Inflammation Research | Issue 10/2020

Login to get access

Abstract

The 49th annual meeting of the European Histamine Research Society (EHRS) was planned to be held at ‘Die Wolfsburg’, Mühlheim an der Ruhr near Düsseldorf in Germany. With the announcement of the COVID-19 pandemic, the face-to-face conference meeting was cancelled and instead, the EHRS Council proposed an Online Symposium to keep up the good spirits and research enthusiasm of the Society members. This meeting report summarises two 2 h sessions held on 1st and 2nd July, 2020 and delivered via Blackboard Collaborate. The Online Symposium covered a range of interesting and inspiring topics around the molecular and clinical pharmacology of histamine, with nine exciting presentations delivered by young and senior members of the Society across both days.
Metadata
Title
Meeting report of the 49th annual meeting of the European Histamine Research Society (EHRS)
Authors
Linda Kay
Ilona Obara
Publication date
01-10-2020
Publisher
Springer International Publishing
Published in
Inflammation Research / Issue 10/2020
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-020-01390-6

Other articles of this Issue 10/2020

Inflammation Research 10/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.